Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.
Researchers are decoding how signals move between body and brain, with implications for how we understand and treat ...
Scientists have taken a small but significant step toward testing the idea of reverse aging in humans. Researchers have ...
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now being tested in humans.
Morning Overview on MSN
A Harvard scientist says his team is preparing the first human trials aimed at reversing aging
A team linked to Harvard Medical School has dosed the first patient in a clinical trial designed to reverse cellular aging in ...
The Daily Galaxy on MSN
Scientists are testing a cellular reset that could push aging human cells back toward youth
Aging, at its most fundamental level, is a molecular process. Chemical marks on the genome shift and lose fidelity over time, ...
Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.
Biotech startup NewLimit secures a major funding round after claiming a ‘breakthrough discovery’ of a prototype medicine that rewinds cellular aging in the liver.
As AI transforms biology, longevity startups are attracting investors, advancing toward clinical milestones, and reshaping ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results